Association Between Sarcopenic Obesity and Mortality in Patients on Peritoneal Dialysis: a Prospective Cohort Study

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Mar 7

PMID 38449887

Authors

Yiwei Shen

Xinyu Su

Zanzhe Yu

Hao Yan

Dahua Ma

Yimei Xu

Jiangzi Yuan

Zhaohui Ni

Leyi Gu

Wei Fang

Affiliations

Soon will be listed here.

Abstract

Background: Whether sarcopenic obesity had unfavorable effect on survival of peritoneal dialysis (PD) patients is unknown. We aimed to investigate the association between sarcopenic obesity and survival in PD patients.

Methods: This was a prospective observational study. Eligible PD patients from November 2016 to December 2017 were enrolled and followed until August 31, 2023. Sarcopenia was defined following the recommendations of the Asian Working Group for Sarcopenia (AWGS) as low appendicular skeletal muscle mass index (ASMI) and handgrip strength (HGS). Obesity was defined using the percentage of body fat (PBF). Survival analysis was conducted using the Kaplan-Meier and log-rank test. The Cox regression and the cumulative incidence competing risk (CICR) analyzes were used to investigate the association between sarcopenic obesity and all-cause mortality.

Results: A total of 223 patients were enrolled with 133 (59.6%) males, a median age of 57.5 (44.6, 65.7) years, a median dialysis vintage of 20.3 (6.4, 57.7) months and 48 (21.5%) who had comorbid diabetes mellitus. Among them, 46 (20.6%) patients were sarcopenic, and 25 (11.2%) patients were diagnosed with sarcopenic obesity. After followed up for 51.6 (25.6, 73.9) months, the Kaplan-Meier curve showed the sarcopenic obesity (log-rank = 13.527, < 0.001) group had significant lower survival rate compared to the nonsarcopenic non-obesity group. For multivariate analysis, the CICR method showed patients with sarcopenic obesity had significantly higher mortality rate (HR: 2.190, 95% CI: 1.011-4.743, = 0.047) compared to those with nonsarcopenic non-obesity.

Conclusion: Sarcopenia is not uncommon in PD patients, with a considerable proportion having sarcopenic obesity. There is a significant association between sarcopenic obesity and an increased risk of mortality in PD patients.

Citing Articles

Clinical and novel insights into risk factors for sarcopenia in dialysis patients: a systematic review and meta-analysis.

Zhang Y, Zhang Z, Cao Z, Bai X, Zhang S, Zhang S BMC Musculoskelet Disord. 2025; 26(1):58.

PMID: 39825310 PMC: 11742487. DOI: 10.1186/s12891-025-08317-4.

References

Beberashvili I, Azar A, Khatib A, Hamad R, Neheman A, Efrati S . Sarcopenic Obesity Versus Nonobese Sarcopenia in Hemodialysis Patients: Differences in Nutritional Status, Quality of Life, and Clinical Outcomes. J Ren Nutr. 2022; 33(1):147-156. DOI: 10.1053/j.jrn.2022.05.003. View

Janssen I, Heymsfield S, Ross R . Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50(5):889-96. DOI: 10.1046/j.1532-5415.2002.50216.x. View

Wu J, Guan J, Lin S, Wu X, Ding M, Ren Z . Prediction of sarcopenia among peritoneal dialysis patients using a combination of irisin and phase angle. Nephrol Ther. 2023; 19(1):66-75. DOI: 10.1684/ndt.2023.7. View

Nolph K, Moore H, Twardowski Z, Khanna R, Prowant B, Meyer M . Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J. 1992; 38(3):M139-42. DOI: 10.1097/00002480-199207000-00004. View

Teitelbaum I, Finkelstein F . Why are we Not Getting More Patients onto Peritoneal Dialysis? Observations From the United States with Global Implications. Kidney Int Rep. 2023; 8(10):1917-1923. PMC: 10577320. DOI: 10.1016/j.ekir.2023.07.012. View

Vonesh E, Snyder J, Foley R, Collins A . Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?. Kidney Int Suppl. 2006; (103):S3-11. DOI: 10.1038/sj.ki.5001910. View

Malhotra R, Deger S, Salat H, Bian A, Stewart T, Booker C . Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis Patients. J Ren Nutr. 2016; 27(2):84-90. PMC: 5318243. DOI: 10.1053/j.jrn.2016.09.010. View

Han S, Han D . Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol. 2012; 8(3):163-75. DOI: 10.1038/nrneph.2012.12. View

van Olden R, Krediet R, Struijk D, Arisz L . Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996; 7(5):745-50. DOI: 10.1681/ASN.V75745. View

10.

Kalantar-Zadeh K, Ikizler T, Block G, Avram M, Kopple J . Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003; 42(5):864-81. DOI: 10.1016/j.ajkd.2003.07.016. View

11.

Tanaka H, Kitamura G, Nankaku M, Taniguchi M, Shide K, Fujita M . Association of Physical Activity and Nutritional Intake with Muscle Quantity and Quality Changes in Acute Stroke Patients. J Stroke Cerebrovasc Dis. 2022; 31(6):106442. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106442. View

12.

Baumgartner R, Wayne S, Waters D, Janssen I, Gallagher D, Morley J . Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2005; 12(12):1995-2004. DOI: 10.1038/oby.2004.250. View

13.

Battaglia Y, Ullo I, Massarenti S, Esposito P, Prencipe M, Ciancio G . Ultrasonography of Quadriceps Femoris Muscle and Subcutaneous Fat Tissue and Body Composition by BIVA in Chronic Dialysis Patients. Nutrients. 2020; 12(5). PMC: 7285004. DOI: 10.3390/nu12051388. View

14.

Than W, Ng J, Chan G, Fung W, Chow K, Szeto C . The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years. Clin Kidney J. 2022; 15(1):70-78. PMC: 8757419. DOI: 10.1093/ckj/sfab139. View

15.

Kam-Tao Li P, Chow K, van de Luijtgaarden M, Johnson D, Jager K, Mehrotra R . Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2016; 13(2):90-103. DOI: 10.1038/nrneph.2016.181. View

16.

Twardowski Z . Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989; 7(2-3):95-108. DOI: 10.1159/000169582. View

17.

Yoowannakul S, Tangvoraphonkchai K, Davenport A . The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr. 2017; 72(3):381-387. DOI: 10.1038/s41430-017-0033-6. View

18.

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

19.

Cheng L, Tang W, Wang T . Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005; 45(5):891-902. DOI: 10.1053/j.ajkd.2005.01.037. View

20.

Atkins J, Wannamathee S . Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr. 2020; 124(10):1102-1113. DOI: 10.1017/S0007114520002172. View